BETA
Your AI-Trained Oncology Knowledge Connection!
A summary of key discussion points and an overview of the evidence presented to inform the dialogue.
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Subcutaneous Daratumumab Improves PFS in Smoldering Multiple Myeloma
Navigating AE Management for Cellular Therapy Across Hematologic Cancers
Weekly Carfilzomib Combination Shows MRD Negativity in Multiple Myeloma
Mitigating AEs and Protecting QOL Following Talquetamab in Multiple Myeloma
Further Research on Anti-CD38 mAbs Warranted in Multiple Myeloma
Carfilzomib Regimens Improve MRD Outcomes in Older, Fit NDMM Population